#ACTRIMS2021 – Research Examines T-cells’ Anti-inflammatory Potential

#ACTRIMS2021 – Research Examines T-cells’ Anti-inflammatory Potential

288059

#ACTRIMS2021 – Research Examines T-cells’ Anti-inflammatory Potential

Editor’s note: The Multiple Sclerosis News Today news team is providing in-depth and unparalleled coverage of the virtual ACTRIMS Forum 2021, Feb. 25–27. Go here to see the latest stories from the conference. Regulatory immune cells expressing the melanoma cell adhesion molecule (MCAM) dampen inflammation at sites of nerve damage in multiple sclerosis (MS), making them a potential therapeutic candidate. T-cells play a central role in the body’s immune response, recognizing and destroying foreign molecules and diseased cells.…

You must be logged in to read/download the full post.